0001809817-22-000002.txt : 20220923 0001809817-22-000002.hdr.sgml : 20220923 20220923150031 ACCESSION NUMBER: 0001809817-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220923 DATE AS OF CHANGE: 20220923 EFFECTIVENESS DATE: 20220923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: March Therapeutics, Inc. CENTRAL INDEX KEY: 0001809817 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-459743 FILM NUMBER: 221262047 BUSINESS ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-294-9558 MAIL ADDRESS: STREET 1: 700 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: MitoLab Inc. DATE OF NAME CHANGE: 20200416 D 1 primary_doc.xml X0708 D LIVE 0001809817 March Therapeutics, Inc. 700 MAIN STREET CAMBRIDGE MA MASSACHUSETTS 02139 617-294-9558 DELAWARE MitoLab Inc. Corporation true 2020 Jeong Seuk Kang c/o March Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Fahim Farzadfard c/o March Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Clare Ozawa c/o March Therapeutics, Inc. 700 Main Street Cambridge MA MASSACHUSETTS 02139 Director Other Health Care Decline to Disclose 06b false 2022-09-12 false true true false 0 30300000 20300000 10000000 false 3 0 0 0 false March Therapeutics, Inc. /s/Jeong Seuk Kang Jeong Seuk Kang Chief Executive Officer 2022-09-21